Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy

Kwan Hwa Chi, Yu Shan Wang, Yi Chun Huang, Hsin Chien Chiang, Mau Shin Chi, Chau Hwa Chi, Hsin Ell Wang, Shang Jyh Kao

研究成果: 雜誌貢獻文章同行評審

23 引文 斯高帕斯(Scopus)


While combined chemotherapy (CT) with an autophagy inducer and an autophagy inhibitor appears paradoxical, it may provide a more effective perturbation of autophagy pathways. We used two dissimilar cell lines to test the hypothesis that autophagy is the common denominator of cell fate after CT. HA22T cells are characterized by CT-induced apoptosis and use autophagy to prevent cell death, while Huh7.5.1 cells exhibit sustained autophagic morphology after CT. Combined CT and rapamycin treatment resulted in a better combination index (CI) in Huh7.5.1 cells than combined CT and chloroquine, while the reverse was true in HA22T cells. The combination of 3 drugs (triplet drug treatment) had the best CI. After triplet drug treatment, HA22T cells switched from protective autophagy to mitochondrial membrane permeabilization and endoplasmic reticulum stress response-induced apoptosis, while Huh7.5.1 cells intensified autophagic lethality. Most importantly, both cell lines showed activation of Akt after CT, while the triplet combination blocked Akt activation through inhibition of phospholipid lipase D activity. This novel finding warrants further investigation as a broad chemosensitization strategy.

頁(從 - 到)58075-58088
出版狀態已發佈 - 2016

ASJC Scopus subject areas

  • 腫瘤科


深入研究「Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy」主題。共同形成了獨特的指紋。